Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein.

Brien G, Debaud AL, Bickle M, Trescol-Biemont MC, Moncorge O, Colas P, Bonnefoy-Berard N.

Biochemistry. 2011 Jun 14;50(23):5120-9. doi: 10.1021/bi101839p. Epub 2011 May 20.

PMID:
21563784
2.

C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1.

Brien G, Debaud AL, Robert X, Oliver L, Trescol-Biemont MC, Cauquil N, Geneste O, Aghajari N, Vallette FM, Haser R, Bonnefoy-Berard N.

J Biol Chem. 2009 Oct 30;284(44):30257-63. doi: 10.1074/jbc.M109.040824. Epub 2009 Sep 15.

3.

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P, Durieu I, Tebib J, Kassai B, Ansieau S, Puisieux A, Eliaou JF, Bonnefoy-Bérard N.

Nat Immunol. 2009 Jul;10(7):778-85. doi: 10.1038/ni.1741. Epub 2009 May 31. Retraction in: Nat Immunol. 2014 Sep;15(9):894.

PMID:
19483719
4.

Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus.

Andre J, Cimaz R, Ranchin B, Galambrun C, Bertrand Y, Bouvier R, Rieux-Laucat F, Trescol-Biemont MC, Cochat P, Bonnefoy-Berard N.

Lupus. 2007;16(2):95-100.

PMID:
17402365
5.

Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.

Brien G, Trescol-Biemont MC, Bonnefoy-Bérard N.

Oncogene. 2007 Aug 23;26(39):5828-32. Epub 2007 Mar 12.

PMID:
17353899
6.

Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection.

Verschelde C, Michonneau D, Trescol-Biemont MC, Berberich I, Schimpl A, Bonnefoy-Berard N.

Cell Death Differ. 2006 Jul;13(7):1213-21. Epub 2005 Nov 18.

7.

Regulation of A1/Bfl-1 expression in peripheral splenic B cells.

Trescol-Biémont MC, Verschelde C, Cottalorda A, Bonnefoy-Bérard N.

Biochimie. 2004 Apr-May;86(4-5):287-94.

PMID:
15194232
8.

Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression.

Laine D, Trescol-Biémont MC, Longhi S, Libeau G, Marie JC, Vidalain PO, Azocar O, Diallo A, Canard B, Rabourdin-Combe C, Valentin H.

J Virol. 2003 Nov;77(21):11332-46.

9.

Mechanism of measles virus-induced suppression of inflammatory immune responses.

Marie JC, Kehren J, Trescol-Biémont MC, Evlashev A, Valentin H, Walzer T, Tedone R, Loveland B, Nicolas JF, Rabourdin-Combe C, Horvat B.

Immunity. 2001 Jan;14(1):69-79.

10.

Conformational restriction of the Tyr53 side-chain in the decapeptide HE.

Casimir JR, Iterbeke K, Van Den Nest W, Trescol-Biémont MC, Dumortier H, Muller S, Gerlier D, Rabourdin-Combe C, Tourwé D, Paris J.

J Pept Res. 2000 Dec;56(6):398-408.

PMID:
11152299
11.

Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation.

Astier A, Trescol-Biémont MC, Azocar O, Lamouille B, Rabourdin-Combe C.

J Immunol. 2000 Jun 15;164(12):6091-5.

12.

Productive measles virus brain infection and apoptosis in CD46 transgenic mice.

Evlashev A, Moyse E, Valentin H, Azocar O, Trescol-Biémont MC, Marie JC, Rabourdin-Combe C, Horvat B.

J Virol. 2000 Feb;74(3):1373-82.

13.

Death by neglect as a deletional mechanism of peripheral tolerance.

Bertolino P, Trescol-Biémont MC, Thomas J, Fazekas de St Groth B, Pihlgren M, Marvel J, Rabourdin-Combe C.

Int Immunol. 1999 Aug;11(8):1225-38.

PMID:
10421780
14.

Molecular modeling of hen egg lysozyme HEL[52-61] peptide binding to I-Ak MHC class II molecule.

Weber P, Raynaud I, Ettouati L, Trescol-Biémont MC, Carrupt PA, Paris J, Rabourdin-Combe C, Gerlier D, Testa B.

Int Immunol. 1998 Dec;10(12):1753-64.

PMID:
9885896
15.

An accessory peptide binding site with allosteric effect on the formation of peptide-MHC-II complexes?

Gerlier D, Trescol-Biémont MC, Ettouati L, Paris J, Rabourdin-Combe C.

C R Acad Sci III. 1998 Jan;321(1):19-24. Review.

PMID:
9759354
16.

Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD46.

Rivailler P, Trescol-Biémont MC, Gimenez C, Rabourdin-Combe C, Horvat B.

Eur J Immunol. 1998 Apr;28(4):1301-14.

17.

Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival.

Bertolino P, Trescol-Biémont MC, Rabourdin-Combe C.

Eur J Immunol. 1998 Jan;28(1):221-36.

18.

Substitution of peptide bond 53-54 of HEL(52-61) with an ethylene bond rather than reduced peptide bond is tolerated by an MHC-II restricted T cell.

Ettouati L, Salvi JP, Trescol-Biémont MC, Walchshofer N, Gerlier D, Rabourdin-Combe C, Paris J.

Pept Res. 1996 Sep-Oct;9(5):248-53.

PMID:
9000251
19.

Quantification of measles virus by a virus receptor-dependent and haemagglutinin-specific T cell stimulation assay.

Trescol-Biémont MC, Leonov S, Rabourdin-Combe C, Gerlier D.

J Immunol Methods. 1995 Dec 1;187(2):253-8.

PMID:
7499884
20.

Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.

Bertolino P, Staschewski M, Trescol-Biémont MC, Freisewinkel IM, Schenck K, Chrétien I, Forquet F, Gerlier D, Rabourdin-Combe C, Koch N.

J Immunol. 1995 Jun 1;154(11):5620-9.

PMID:
7751615
22.

Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway.

Gerlier D, Trescol-Biémont MC, Varior-Krishnan G, Naniche D, Fugier-Vivier I, Rabourdin-Combe C.

Cell Biol Int. 1994 May;18(5):315-20.

PMID:
8049676
23.
24.

Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?

Calin-Laurens V, Trescol-Biémont MC, Gerlier D, Rabourdin-Combe C.

Vaccine. 1993;11(9):974-8.

PMID:
7692684
25.

High efficiency of endogenous antigen presentation by MHC class II molecules.

Calin-Laurens V, Forquet F, Lombard-Platet S, Bertolino P, Chrétien I, Trescol-Biémont MC, Gerlier D, Rabourdin-Combe C.

Int Immunol. 1992 Oct;4(10):1113-21.

PMID:
1336977
26.

Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.

Forquet F, Calin V, Trescol-Biemont MC, Kanellopoulos J, Mottez E, Kourilsky P, Rabourdin-Combe C, Gerlier D.

Eur J Immunol. 1990 Oct;20(10):2325-32.

PMID:
2242761
27.
28.

Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.

Manet E, Gruffat H, Trescol-Biemont MC, Moreno N, Chambard P, Giot JF, Sergeant A.

EMBO J. 1989 Jun;8(6):1819-26.

29.

Localization polymorphism of EBV DNA genomes in the chromosomes of Burkitt lymphoma cell lines.

Trescol-Biémont MC, Biémont C, Daillie J.

Chromosoma. 1987;95(2):144-7.

PMID:
3036436

Supplemental Content

Loading ...
Support Center